nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—chronic kidney failure—Calcitriol—psoriasis	0.352	0.54	CpDpCtD
Cinacalcet—chronic kidney failure—Cholecalciferol—psoriasis	0.299	0.46	CpDpCtD
Cinacalcet—CYP1A2—Clobetasol propionate—psoriasis	0.054	0.225	CbGbCtD
Cinacalcet—CYP1A2—Methoxsalen—psoriasis	0.0284	0.118	CbGbCtD
Cinacalcet—CYP2D6—Hydroxyurea—psoriasis	0.0255	0.106	CbGbCtD
Cinacalcet—CYP3A4—Calcitriol—psoriasis	0.0191	0.0796	CbGbCtD
Cinacalcet—CYP2D6—Cholecalciferol—psoriasis	0.0155	0.0645	CbGbCtD
Cinacalcet—CYP3A4—Methoxsalen—psoriasis	0.0149	0.0619	CbGbCtD
Cinacalcet—CYP2D6—Cyclosporine—psoriasis	0.0102	0.0424	CbGbCtD
Cinacalcet—CYP3A4—Cholecalciferol—psoriasis	0.00984	0.041	CbGbCtD
Cinacalcet—CYP3A4—Mycophenolate mofetil—psoriasis	0.00853	0.0355	CbGbCtD
Cinacalcet—CYP3A4—Triamcinolone—psoriasis	0.00853	0.0355	CbGbCtD
Cinacalcet—CYP3A4—Betamethasone—psoriasis	0.00732	0.0305	CbGbCtD
Cinacalcet—CYP3A4—Prednisolone—psoriasis	0.00722	0.0301	CbGbCtD
Cinacalcet—CYP3A4—Hydrocortisone—psoriasis	0.00685	0.0285	CbGbCtD
Cinacalcet—CYP3A4—Prednisone—psoriasis	0.00682	0.0284	CbGbCtD
Cinacalcet—CYP2D6—Dexamethasone—psoriasis	0.0067	0.0279	CbGbCtD
Cinacalcet—CYP3A4—Cyclosporine—psoriasis	0.00647	0.0269	CbGbCtD
Cinacalcet—CYP3A4—Dexamethasone—psoriasis	0.00426	0.0177	CbGbCtD
Cinacalcet—CASR—G alpha (i) signalling events—HCAR2—psoriasis	0.000333	0.0842	CbGpPWpGaD
Cinacalcet—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000314	0.0794	CbGpPWpGaD
Cinacalcet—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000293	0.0741	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—HCAR2—psoriasis	0.000201	0.051	CbGpPWpGaD
Cinacalcet—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000195	0.0492	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CCL20—psoriasis	0.000173	0.0437	CbGpPWpGaD
Cinacalcet—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000165	0.0417	CbGpPWpGaD
Cinacalcet—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000127	0.0322	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—HCAR2—psoriasis	0.000114	0.0288	CbGpPWpGaD
Cinacalcet—Convulsion—Prednisolone—psoriasis	0.000105	0.00101	CcSEcCtD
Cinacalcet—Hypertension—Prednisolone—psoriasis	0.000105	0.001	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CCL20—psoriasis	0.000105	0.0265	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000104	0.000998	CcSEcCtD
Cinacalcet—Arrhythmia—Dexamethasone—psoriasis	0.000104	0.000996	CcSEcCtD
Cinacalcet—Arrhythmia—Betamethasone—psoriasis	0.000104	0.000996	CcSEcCtD
Cinacalcet—Anorexia—Cyclosporine—psoriasis	0.000104	0.000994	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—HCAR2—psoriasis	0.000103	0.0262	CbGpPWpGaD
Cinacalcet—Skin disorder—Mycophenolate mofetil—psoriasis	0.000103	0.000988	CcSEcCtD
Cinacalcet—Convulsion—Hydrocortisone—psoriasis	0.000103	0.000984	CcSEcCtD
Cinacalcet—Hypertension—Hydrocortisone—psoriasis	0.000102	0.000981	CcSEcCtD
Cinacalcet—Vomiting—Hydroxyurea—psoriasis	0.000102	0.000979	CcSEcCtD
Cinacalcet—Angioedema—Triamcinolone—psoriasis	0.000102	0.000977	CcSEcCtD
Cinacalcet—Rash—Hydroxyurea—psoriasis	0.000101	0.000971	CcSEcCtD
Cinacalcet—Anorexia—Mycophenolate mofetil—psoriasis	0.000101	0.00097	CcSEcCtD
Cinacalcet—Dermatitis—Hydroxyurea—psoriasis	0.000101	0.00097	CcSEcCtD
Cinacalcet—Myalgia—Hydrocortisone—psoriasis	0.000101	0.000967	CcSEcCtD
Cinacalcet—Headache—Hydroxyurea—psoriasis	0.000101	0.000965	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.0001	0.00096	CcSEcCtD
Cinacalcet—Hypotension—Mycophenolate mofetil—psoriasis	9.93e-05	0.000951	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Cyclosporine—psoriasis	9.92e-05	0.00095	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Methotrexate—psoriasis	9.84e-05	0.000942	CcSEcCtD
Cinacalcet—Paraesthesia—Cyclosporine—psoriasis	9.78e-05	0.000937	CcSEcCtD
Cinacalcet—Cough—Triamcinolone—psoriasis	9.75e-05	0.000933	CcSEcCtD
Cinacalcet—Dyspnoea—Cyclosporine—psoriasis	9.71e-05	0.00093	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	9.68e-05	0.000927	CcSEcCtD
Cinacalcet—Convulsion—Triamcinolone—psoriasis	9.68e-05	0.000927	CcSEcCtD
Cinacalcet—Asthenia—Mycophenolic acid—psoriasis	9.66e-05	0.000925	CcSEcCtD
Cinacalcet—Hypertension—Triamcinolone—psoriasis	9.64e-05	0.000923	CcSEcCtD
Cinacalcet—Infection—Hydrocortisone—psoriasis	9.62e-05	0.000921	CcSEcCtD
Cinacalcet—Dyspepsia—Cyclosporine—psoriasis	9.59e-05	0.000918	CcSEcCtD
Cinacalcet—Nausea—Hydroxyurea—psoriasis	9.55e-05	0.000915	CcSEcCtD
Cinacalcet—Paraesthesia—Mycophenolate mofetil—psoriasis	9.54e-05	0.000914	CcSEcCtD
Cinacalcet—Pruritus—Mycophenolic acid—psoriasis	9.53e-05	0.000912	CcSEcCtD
Cinacalcet—Myalgia—Triamcinolone—psoriasis	9.51e-05	0.000911	CcSEcCtD
Cinacalcet—Nervous system disorder—Hydrocortisone—psoriasis	9.49e-05	0.000909	CcSEcCtD
Cinacalcet—Dyspnoea—Mycophenolate mofetil—psoriasis	9.47e-05	0.000907	CcSEcCtD
Cinacalcet—Decreased appetite—Cyclosporine—psoriasis	9.47e-05	0.000907	CcSEcCtD
Cinacalcet—Depression—Methotrexate—psoriasis	9.41e-05	0.000901	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Cyclosporine—psoriasis	9.4e-05	0.000901	CcSEcCtD
Cinacalcet—Skin disorder—Hydrocortisone—psoriasis	9.4e-05	0.000901	CcSEcCtD
Cinacalcet—Fatigue—Cyclosporine—psoriasis	9.39e-05	0.000899	CcSEcCtD
Cinacalcet—Dyspepsia—Mycophenolate mofetil—psoriasis	9.35e-05	0.000896	CcSEcCtD
Cinacalcet—Constipation—Cyclosporine—psoriasis	9.32e-05	0.000892	CcSEcCtD
Cinacalcet—Angioedema—Betamethasone—psoriasis	9.26e-05	0.000887	CcSEcCtD
Cinacalcet—Angioedema—Dexamethasone—psoriasis	9.26e-05	0.000887	CcSEcCtD
Cinacalcet—Decreased appetite—Mycophenolate mofetil—psoriasis	9.24e-05	0.000885	CcSEcCtD
Cinacalcet—Anorexia—Hydrocortisone—psoriasis	9.23e-05	0.000884	CcSEcCtD
Cinacalcet—Diarrhoea—Mycophenolic acid—psoriasis	9.21e-05	0.000882	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.17e-05	0.000879	CcSEcCtD
Cinacalcet—Immune system disorder—Prednisone—psoriasis	9.16e-05	0.000877	CcSEcCtD
Cinacalcet—Constipation—Mycophenolate mofetil—psoriasis	9.09e-05	0.00087	CcSEcCtD
Cinacalcet—Arrhythmia—Prednisone—psoriasis	9.06e-05	0.000867	CcSEcCtD
Cinacalcet—Infection—Triamcinolone—psoriasis	9.06e-05	0.000867	CcSEcCtD
Cinacalcet—Hypotension—Hydrocortisone—psoriasis	9.05e-05	0.000866	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Cyclosporine—psoriasis	8.91e-05	0.000853	CcSEcCtD
Cinacalcet—Dizziness—Mycophenolic acid—psoriasis	8.9e-05	0.000853	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisolone—psoriasis	8.9e-05	0.000852	CcSEcCtD
Cinacalcet—Malnutrition—Prednisone—psoriasis	8.83e-05	0.000845	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.82e-05	0.000845	CcSEcCtD
Cinacalcet—Convulsion—Betamethasone—psoriasis	8.78e-05	0.000841	CcSEcCtD
Cinacalcet—Convulsion—Dexamethasone—psoriasis	8.78e-05	0.000841	CcSEcCtD
Cinacalcet—Hypertension—Dexamethasone—psoriasis	8.75e-05	0.000838	CcSEcCtD
Cinacalcet—Hypertension—Betamethasone—psoriasis	8.75e-05	0.000838	CcSEcCtD
Cinacalcet—Paraesthesia—Hydrocortisone—psoriasis	8.69e-05	0.000832	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	8.69e-05	0.000832	CcSEcCtD
Cinacalcet—Urticaria—Cyclosporine—psoriasis	8.65e-05	0.000829	CcSEcCtD
Cinacalcet—Myalgia—Betamethasone—psoriasis	8.63e-05	0.000826	CcSEcCtD
Cinacalcet—Myalgia—Dexamethasone—psoriasis	8.63e-05	0.000826	CcSEcCtD
Cinacalcet—Abdominal pain—Cyclosporine—psoriasis	8.61e-05	0.000825	CcSEcCtD
Cinacalcet—Body temperature increased—Cyclosporine—psoriasis	8.61e-05	0.000825	CcSEcCtD
Cinacalcet—Vomiting—Mycophenolic acid—psoriasis	8.56e-05	0.00082	CcSEcCtD
Cinacalcet—Dyspepsia—Hydrocortisone—psoriasis	8.52e-05	0.000816	CcSEcCtD
Cinacalcet—Rash—Mycophenolic acid—psoriasis	8.49e-05	0.000813	CcSEcCtD
Cinacalcet—Dermatitis—Mycophenolic acid—psoriasis	8.48e-05	0.000812	CcSEcCtD
Cinacalcet—Urticaria—Mycophenolate mofetil—psoriasis	8.44e-05	0.000808	CcSEcCtD
Cinacalcet—Headache—Mycophenolic acid—psoriasis	8.44e-05	0.000808	CcSEcCtD
Cinacalcet—Decreased appetite—Hydrocortisone—psoriasis	8.42e-05	0.000806	CcSEcCtD
Cinacalcet—Abdominal pain—Mycophenolate mofetil—psoriasis	8.4e-05	0.000804	CcSEcCtD
Cinacalcet—Body temperature increased—Mycophenolate mofetil—psoriasis	8.4e-05	0.000804	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.36e-05	0.0008	CcSEcCtD
Cinacalcet—Fatigue—Hydrocortisone—psoriasis	8.35e-05	0.000799	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.3e-05	0.000795	CcSEcCtD
Cinacalcet—Infection—Betamethasone—psoriasis	8.22e-05	0.000787	CcSEcCtD
Cinacalcet—Infection—Dexamethasone—psoriasis	8.22e-05	0.000787	CcSEcCtD
Cinacalcet—Paraesthesia—Triamcinolone—psoriasis	8.19e-05	0.000784	CcSEcCtD
Cinacalcet—Anaemia—Prednisone—psoriasis	8.16e-05	0.000781	CcSEcCtD
Cinacalcet—Dyspnoea—Triamcinolone—psoriasis	8.13e-05	0.000778	CcSEcCtD
Cinacalcet—Nervous system disorder—Dexamethasone—psoriasis	8.11e-05	0.000777	CcSEcCtD
Cinacalcet—Nervous system disorder—Betamethasone—psoriasis	8.11e-05	0.000777	CcSEcCtD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	8.08e-05	0.0204	CbGpPWpGaD
Cinacalcet—Angioedema—Prednisone—psoriasis	8.06e-05	0.000772	CcSEcCtD
Cinacalcet—Hypersensitivity—Cyclosporine—psoriasis	8.03e-05	0.000769	CcSEcCtD
Cinacalcet—Dyspepsia—Triamcinolone—psoriasis	8.02e-05	0.000768	CcSEcCtD
Cinacalcet—Nausea—Mycophenolic acid—psoriasis	8e-05	0.000766	CcSEcCtD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.98e-05	0.0202	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Hydrocortisone—psoriasis	7.92e-05	0.000758	CcSEcCtD
Cinacalcet—Anorexia—Dexamethasone—psoriasis	7.88e-05	0.000755	CcSEcCtD
Cinacalcet—Anorexia—Betamethasone—psoriasis	7.88e-05	0.000755	CcSEcCtD
Cinacalcet—Urticaria—Prednisolone—psoriasis	7.87e-05	0.000754	CcSEcCtD
Cinacalcet—Fatigue—Triamcinolone—psoriasis	7.86e-05	0.000753	CcSEcCtD
Cinacalcet—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.83e-05	0.00075	CcSEcCtD
Cinacalcet—Asthenia—Cyclosporine—psoriasis	7.82e-05	0.000748	CcSEcCtD
Cinacalcet—Hypotension—Dexamethasone—psoriasis	7.73e-05	0.00074	CcSEcCtD
Cinacalcet—Hypotension—Betamethasone—psoriasis	7.73e-05	0.00074	CcSEcCtD
Cinacalcet—Pruritus—Cyclosporine—psoriasis	7.71e-05	0.000738	CcSEcCtD
Cinacalcet—Urticaria—Hydrocortisone—psoriasis	7.69e-05	0.000737	CcSEcCtD
Cinacalcet—Immune system disorder—Methotrexate—psoriasis	7.65e-05	0.000733	CcSEcCtD
Cinacalcet—Body temperature increased—Hydrocortisone—psoriasis	7.65e-05	0.000733	CcSEcCtD
Cinacalcet—Abdominal pain—Hydrocortisone—psoriasis	7.65e-05	0.000733	CcSEcCtD
Cinacalcet—Convulsion—Prednisone—psoriasis	7.65e-05	0.000732	CcSEcCtD
Cinacalcet—Asthenia—Mycophenolate mofetil—psoriasis	7.62e-05	0.00073	CcSEcCtD
Cinacalcet—Hypertension—Prednisone—psoriasis	7.62e-05	0.00073	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Betamethasone—psoriasis	7.54e-05	0.000722	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.54e-05	0.000722	CcSEcCtD
Cinacalcet—Pruritus—Mycophenolate mofetil—psoriasis	7.52e-05	0.00072	CcSEcCtD
Cinacalcet—Arthralgia—Prednisone—psoriasis	7.51e-05	0.00072	CcSEcCtD
Cinacalcet—Myalgia—Prednisone—psoriasis	7.51e-05	0.00072	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.46e-05	0.000715	CcSEcCtD
Cinacalcet—Diarrhoea—Cyclosporine—psoriasis	7.45e-05	0.000714	CcSEcCtD
Cinacalcet—Paraesthesia—Betamethasone—psoriasis	7.43e-05	0.000711	CcSEcCtD
Cinacalcet—Paraesthesia—Dexamethasone—psoriasis	7.43e-05	0.000711	CcSEcCtD
Cinacalcet—Malnutrition—Methotrexate—psoriasis	7.38e-05	0.000706	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisolone—psoriasis	7.3e-05	0.000699	CcSEcCtD
Cinacalcet—Dyspepsia—Betamethasone—psoriasis	7.28e-05	0.000697	CcSEcCtD
Cinacalcet—Dyspepsia—Dexamethasone—psoriasis	7.28e-05	0.000697	CcSEcCtD
Cinacalcet—Diarrhoea—Mycophenolate mofetil—psoriasis	7.27e-05	0.000696	CcSEcCtD
Cinacalcet—Urticaria—Triamcinolone—psoriasis	7.24e-05	0.000694	CcSEcCtD
Cinacalcet—Body temperature increased—Triamcinolone—psoriasis	7.21e-05	0.00069	CcSEcCtD
Cinacalcet—Dizziness—Cyclosporine—psoriasis	7.2e-05	0.00069	CcSEcCtD
Cinacalcet—Decreased appetite—Betamethasone—psoriasis	7.19e-05	0.000689	CcSEcCtD
Cinacalcet—Decreased appetite—Dexamethasone—psoriasis	7.19e-05	0.000689	CcSEcCtD
Cinacalcet—Infection—Prednisone—psoriasis	7.16e-05	0.000685	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Betamethasone—psoriasis	7.14e-05	0.000684	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Dexamethasone—psoriasis	7.14e-05	0.000684	CcSEcCtD
Cinacalcet—Hypersensitivity—Hydrocortisone—psoriasis	7.13e-05	0.000683	CcSEcCtD
Cinacalcet—Fatigue—Dexamethasone—psoriasis	7.13e-05	0.000683	CcSEcCtD
Cinacalcet—Fatigue—Betamethasone—psoriasis	7.13e-05	0.000683	CcSEcCtD
Cinacalcet—Nervous system disorder—Prednisone—psoriasis	7.06e-05	0.000676	CcSEcCtD
Cinacalcet—Dizziness—Mycophenolate mofetil—psoriasis	7.03e-05	0.000673	CcSEcCtD
Cinacalcet—Skin disorder—Prednisone—psoriasis	7e-05	0.00067	CcSEcCtD
Cinacalcet—Asthenia—Hydrocortisone—psoriasis	6.95e-05	0.000665	CcSEcCtD
Cinacalcet—Vomiting—Cyclosporine—psoriasis	6.93e-05	0.000663	CcSEcCtD
Cinacalcet—Rash—Cyclosporine—psoriasis	6.87e-05	0.000658	CcSEcCtD
Cinacalcet—Anorexia—Prednisone—psoriasis	6.87e-05	0.000658	CcSEcCtD
Cinacalcet—Dermatitis—Cyclosporine—psoriasis	6.86e-05	0.000657	CcSEcCtD
Cinacalcet—Pruritus—Hydrocortisone—psoriasis	6.85e-05	0.000656	CcSEcCtD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.85e-05	0.0173	CbGpPWpGaD
Cinacalcet—Headache—Cyclosporine—psoriasis	6.82e-05	0.000654	CcSEcCtD
Cinacalcet—Anaemia—Methotrexate—psoriasis	6.82e-05	0.000653	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Dexamethasone—psoriasis	6.76e-05	0.000648	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Betamethasone—psoriasis	6.76e-05	0.000648	CcSEcCtD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.76e-05	0.0171	CbGpPWpGaD
Cinacalcet—Vomiting—Mycophenolate mofetil—psoriasis	6.76e-05	0.000647	CcSEcCtD
Cinacalcet—Hypersensitivity—Triamcinolone—psoriasis	6.72e-05	0.000643	CcSEcCtD
Cinacalcet—Rash—Mycophenolate mofetil—psoriasis	6.7e-05	0.000642	CcSEcCtD
Cinacalcet—Dermatitis—Mycophenolate mofetil—psoriasis	6.69e-05	0.000641	CcSEcCtD
Cinacalcet—Headache—Mycophenolate mofetil—psoriasis	6.66e-05	0.000638	CcSEcCtD
Cinacalcet—Diarrhoea—Hydrocortisone—psoriasis	6.62e-05	0.000634	CcSEcCtD
Cinacalcet—Urticaria—Dexamethasone—psoriasis	6.57e-05	0.000629	CcSEcCtD
Cinacalcet—Urticaria—Betamethasone—psoriasis	6.57e-05	0.000629	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Prednisone—psoriasis	6.56e-05	0.000628	CcSEcCtD
Cinacalcet—Dizziness—Prednisolone—psoriasis	6.55e-05	0.000628	CcSEcCtD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.55e-05	0.0166	CbGpPWpGaD
Cinacalcet—Asthenia—Triamcinolone—psoriasis	6.54e-05	0.000626	CcSEcCtD
Cinacalcet—Abdominal pain—Betamethasone—psoriasis	6.54e-05	0.000626	CcSEcCtD
Cinacalcet—Abdominal pain—Dexamethasone—psoriasis	6.54e-05	0.000626	CcSEcCtD
Cinacalcet—Body temperature increased—Dexamethasone—psoriasis	6.54e-05	0.000626	CcSEcCtD
Cinacalcet—Body temperature increased—Betamethasone—psoriasis	6.54e-05	0.000626	CcSEcCtD
Cinacalcet—Nausea—Cyclosporine—psoriasis	6.47e-05	0.00062	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisone—psoriasis	6.47e-05	0.000619	CcSEcCtD
Cinacalcet—Pruritus—Triamcinolone—psoriasis	6.45e-05	0.000618	CcSEcCtD
Cinacalcet—Cough—Methotrexate—psoriasis	6.44e-05	0.000616	CcSEcCtD
Cinacalcet—Dizziness—Hydrocortisone—psoriasis	6.4e-05	0.000613	CcSEcCtD
Cinacalcet—Convulsion—Methotrexate—psoriasis	6.39e-05	0.000612	CcSEcCtD
Cinacalcet—Dyspepsia—Prednisone—psoriasis	6.34e-05	0.000607	CcSEcCtD
Cinacalcet—Nausea—Mycophenolate mofetil—psoriasis	6.31e-05	0.000604	CcSEcCtD
Cinacalcet—Chest pain—Methotrexate—psoriasis	6.28e-05	0.000601	CcSEcCtD
Cinacalcet—Arthralgia—Methotrexate—psoriasis	6.28e-05	0.000601	CcSEcCtD
Cinacalcet—Myalgia—Methotrexate—psoriasis	6.28e-05	0.000601	CcSEcCtD
Cinacalcet—Decreased appetite—Prednisone—psoriasis	6.26e-05	0.0006	CcSEcCtD
Cinacalcet—Rash—Prednisolone—psoriasis	6.25e-05	0.000599	CcSEcCtD
Cinacalcet—Dermatitis—Prednisolone—psoriasis	6.24e-05	0.000598	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.24e-05	0.000597	CcSEcCtD
Cinacalcet—Fatigue—Prednisone—psoriasis	6.21e-05	0.000595	CcSEcCtD
Cinacalcet—Headache—Prednisolone—psoriasis	6.21e-05	0.000595	CcSEcCtD
Cinacalcet—Constipation—Prednisone—psoriasis	6.16e-05	0.00059	CcSEcCtD
Cinacalcet—Vomiting—Hydrocortisone—psoriasis	6.16e-05	0.000589	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—HCAR2—psoriasis	6.11e-05	0.0154	CbGpPWpGaD
Cinacalcet—Rash—Hydrocortisone—psoriasis	6.1e-05	0.000585	CcSEcCtD
Cinacalcet—Dermatitis—Hydrocortisone—psoriasis	6.1e-05	0.000584	CcSEcCtD
Cinacalcet—Headache—Hydrocortisone—psoriasis	6.06e-05	0.000581	CcSEcCtD
Cinacalcet—Dizziness—Triamcinolone—psoriasis	6.03e-05	0.000577	CcSEcCtD
Cinacalcet—Infection—Methotrexate—psoriasis	5.98e-05	0.000573	CcSEcCtD
Cinacalcet—Asthenia—Dexamethasone—psoriasis	5.93e-05	0.000568	CcSEcCtD
Cinacalcet—Asthenia—Betamethasone—psoriasis	5.93e-05	0.000568	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CCL20—psoriasis	5.91e-05	0.015	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Methotrexate—psoriasis	5.9e-05	0.000565	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Prednisone—psoriasis	5.89e-05	0.000564	CcSEcCtD
Cinacalcet—Nausea—Prednisolone—psoriasis	5.89e-05	0.000564	CcSEcCtD
Cinacalcet—Pruritus—Betamethasone—psoriasis	5.85e-05	0.00056	CcSEcCtD
Cinacalcet—Pruritus—Dexamethasone—psoriasis	5.85e-05	0.00056	CcSEcCtD
Cinacalcet—Skin disorder—Methotrexate—psoriasis	5.85e-05	0.00056	CcSEcCtD
Cinacalcet—Vomiting—Triamcinolone—psoriasis	5.8e-05	0.000555	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	5.76e-05	0.0146	CbGpPWpGaD
Cinacalcet—Nausea—Hydrocortisone—psoriasis	5.75e-05	0.000551	CcSEcCtD
Cinacalcet—Rash—Triamcinolone—psoriasis	5.75e-05	0.00055	CcSEcCtD
Cinacalcet—Dermatitis—Triamcinolone—psoriasis	5.74e-05	0.00055	CcSEcCtD
Cinacalcet—Anorexia—Methotrexate—psoriasis	5.74e-05	0.00055	CcSEcCtD
Cinacalcet—Urticaria—Prednisone—psoriasis	5.72e-05	0.000548	CcSEcCtD
Cinacalcet—Headache—Triamcinolone—psoriasis	5.71e-05	0.000547	CcSEcCtD
Cinacalcet—Body temperature increased—Prednisone—psoriasis	5.69e-05	0.000545	CcSEcCtD
Cinacalcet—Abdominal pain—Prednisone—psoriasis	5.69e-05	0.000545	CcSEcCtD
Cinacalcet—Diarrhoea—Dexamethasone—psoriasis	5.66e-05	0.000542	CcSEcCtD
Cinacalcet—Diarrhoea—Betamethasone—psoriasis	5.66e-05	0.000542	CcSEcCtD
Cinacalcet—Hypotension—Methotrexate—psoriasis	5.62e-05	0.000539	CcSEcCtD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.55e-05	0.014	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Methotrexate—psoriasis	5.48e-05	0.000525	CcSEcCtD
Cinacalcet—Dizziness—Betamethasone—psoriasis	5.47e-05	0.000524	CcSEcCtD
Cinacalcet—Dizziness—Dexamethasone—psoriasis	5.47e-05	0.000524	CcSEcCtD
Cinacalcet—Nausea—Triamcinolone—psoriasis	5.41e-05	0.000519	CcSEcCtD
Cinacalcet—Paraesthesia—Methotrexate—psoriasis	5.41e-05	0.000518	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL20—psoriasis	5.37e-05	0.0136	CbGpPWpGaD
Cinacalcet—Dyspnoea—Methotrexate—psoriasis	5.37e-05	0.000514	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisone—psoriasis	5.31e-05	0.000508	CcSEcCtD
Cinacalcet—Dyspepsia—Methotrexate—psoriasis	5.3e-05	0.000507	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—TAGAP—psoriasis	5.3e-05	0.0134	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.29e-05	0.0134	CbGpPWpGaD
Cinacalcet—Vomiting—Betamethasone—psoriasis	5.26e-05	0.000504	CcSEcCtD
Cinacalcet—Vomiting—Dexamethasone—psoriasis	5.26e-05	0.000504	CcSEcCtD
Cinacalcet—Decreased appetite—Methotrexate—psoriasis	5.23e-05	0.000501	CcSEcCtD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.22e-05	0.0132	CbGpPWpGaD
Cinacalcet—Rash—Dexamethasone—psoriasis	5.21e-05	0.000499	CcSEcCtD
Cinacalcet—Rash—Betamethasone—psoriasis	5.21e-05	0.000499	CcSEcCtD
Cinacalcet—Dermatitis—Betamethasone—psoriasis	5.21e-05	0.000499	CcSEcCtD
Cinacalcet—Dermatitis—Dexamethasone—psoriasis	5.21e-05	0.000499	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Methotrexate—psoriasis	5.2e-05	0.000498	CcSEcCtD
Cinacalcet—Fatigue—Methotrexate—psoriasis	5.19e-05	0.000497	CcSEcCtD
Cinacalcet—Headache—Betamethasone—psoriasis	5.18e-05	0.000496	CcSEcCtD
Cinacalcet—Headache—Dexamethasone—psoriasis	5.18e-05	0.000496	CcSEcCtD
Cinacalcet—Asthenia—Prednisone—psoriasis	5.17e-05	0.000495	CcSEcCtD
Cinacalcet—Pruritus—Prednisone—psoriasis	5.1e-05	0.000488	CcSEcCtD
Cinacalcet—Diarrhoea—Prednisone—psoriasis	4.93e-05	0.000472	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methotrexate—psoriasis	4.92e-05	0.000471	CcSEcCtD
Cinacalcet—Nausea—Dexamethasone—psoriasis	4.91e-05	0.00047	CcSEcCtD
Cinacalcet—Nausea—Betamethasone—psoriasis	4.91e-05	0.00047	CcSEcCtD
Cinacalcet—Urticaria—Methotrexate—psoriasis	4.78e-05	0.000458	CcSEcCtD
Cinacalcet—Dizziness—Prednisone—psoriasis	4.76e-05	0.000456	CcSEcCtD
Cinacalcet—Body temperature increased—Methotrexate—psoriasis	4.76e-05	0.000456	CcSEcCtD
Cinacalcet—Abdominal pain—Methotrexate—psoriasis	4.76e-05	0.000456	CcSEcCtD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL8—psoriasis	4.67e-05	0.0118	CbGpPWpGaD
Cinacalcet—Vomiting—Prednisone—psoriasis	4.58e-05	0.000439	CcSEcCtD
Cinacalcet—Rash—Prednisone—psoriasis	4.54e-05	0.000435	CcSEcCtD
Cinacalcet—Dermatitis—Prednisone—psoriasis	4.54e-05	0.000435	CcSEcCtD
Cinacalcet—Headache—Prednisone—psoriasis	4.51e-05	0.000432	CcSEcCtD
Cinacalcet—Hypersensitivity—Methotrexate—psoriasis	4.44e-05	0.000425	CcSEcCtD
Cinacalcet—Asthenia—Methotrexate—psoriasis	4.32e-05	0.000414	CcSEcCtD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.28e-05	0.0108	CbGpPWpGaD
Cinacalcet—Nausea—Prednisone—psoriasis	4.28e-05	0.00041	CcSEcCtD
Cinacalcet—Pruritus—Methotrexate—psoriasis	4.26e-05	0.000408	CcSEcCtD
Cinacalcet—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	4.23e-05	0.0107	CbGpPWpGaD
Cinacalcet—Diarrhoea—Methotrexate—psoriasis	4.12e-05	0.000394	CcSEcCtD
Cinacalcet—Dizziness—Methotrexate—psoriasis	3.98e-05	0.000381	CcSEcCtD
Cinacalcet—Vomiting—Methotrexate—psoriasis	3.83e-05	0.000367	CcSEcCtD
Cinacalcet—Rash—Methotrexate—psoriasis	3.8e-05	0.000363	CcSEcCtD
Cinacalcet—Dermatitis—Methotrexate—psoriasis	3.79e-05	0.000363	CcSEcCtD
Cinacalcet—Headache—Methotrexate—psoriasis	3.77e-05	0.000361	CcSEcCtD
Cinacalcet—Nausea—Methotrexate—psoriasis	3.58e-05	0.000342	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—CYP2S1—psoriasis	3.48e-05	0.0088	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	3.43e-05	0.00868	CbGpPWpGaD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	3.38e-05	0.00854	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	3.36e-05	0.00849	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	3.29e-05	0.00831	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCL20—psoriasis	3.17e-05	0.00802	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.15e-05	0.00796	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP2S1—psoriasis	2.95e-05	0.00746	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	2.91e-05	0.00736	CbGpPWpGaD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	2.9e-05	0.00734	CbGpPWpGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	2.86e-05	0.00723	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL8—psoriasis	2.83e-05	0.00715	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.82e-05	0.00712	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—CAT—psoriasis	2.54e-05	0.00644	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.43e-05	0.00614	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP2S1—psoriasis	2.28e-05	0.00576	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	2.24e-05	0.00568	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.19e-05	0.00555	CbGpPWpGaD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	2.01e-05	0.00508	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.96e-05	0.00497	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SOCS1—psoriasis	1.75e-05	0.00442	CbGpPWpGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	1.7e-05	0.0043	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.69e-05	0.00428	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—TYK2—psoriasis	1.67e-05	0.00421	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL8—psoriasis	1.6e-05	0.00404	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL8—psoriasis	1.45e-05	0.00367	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.41e-05	0.00357	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—APOE—psoriasis	1.29e-05	0.00326	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LEP—psoriasis	1.29e-05	0.00326	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.22e-05	0.00309	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NFKBIA—psoriasis	1.2e-05	0.00304	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.18e-05	0.00297	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.07e-05	0.0027	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TYK2—psoriasis	9.84e-06	0.00249	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.14e-06	0.00231	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	9.14e-06	0.00231	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL8—psoriasis	8.57e-06	0.00217	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—psoriasis	8.15e-06	0.00206	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—JUN—psoriasis	7.96e-06	0.00201	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NFKB1—psoriasis	7.67e-06	0.00194	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NDUFA5—psoriasis	7e-06	0.00177	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—psoriasis	6.96e-06	0.00176	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT3—psoriasis	6.89e-06	0.00174	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP2S1—psoriasis	5.95e-06	0.00151	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NDUFA5—psoriasis	5.93e-06	0.0015	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.53e-06	0.0014	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—psoriasis	5.26e-06	0.00133	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP2S1—psoriasis	5.04e-06	0.00128	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—psoriasis	4.81e-06	0.00122	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NDUFA5—psoriasis	4.58e-06	0.00116	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP2S1—psoriasis	3.89e-06	0.000984	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CARM1—psoriasis	2.91e-06	0.000735	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.64e-06	0.000668	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CARM1—psoriasis	2.46e-06	0.000623	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.3e-06	0.000582	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CARM1—psoriasis	1.9e-06	0.000481	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CAT—psoriasis	1.79e-06	0.000452	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CAT—psoriasis	1.51e-06	0.000383	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—APOE—psoriasis	1.39e-06	0.000351	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARG—psoriasis	1.21e-06	0.000306	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—APOE—psoriasis	1.18e-06	0.000298	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CAT—psoriasis	1.17e-06	0.000296	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARG—psoriasis	1.03e-06	0.000259	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—APOE—psoriasis	9.08e-07	0.00023	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARG—psoriasis	7.91e-07	0.0002	CbGpPWpGaD
